In ALS, the activation of p38 MAPK has been proposed to mediate the toxic effects of SOD1 and FUS through glial activation, increase of nitric oxide production, and hyperphosphorylation of neurofilaments26–28. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.